ODPX_HUMAN - dbPTM
ODPX_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ODPX_HUMAN
UniProt AC O00330
Protein Name Pyruvate dehydrogenase protein X component, mitochondrial
Gene Name PDHX
Organism Homo sapiens (Human).
Sequence Length 501
Subcellular Localization Mitochondrion matrix.
Protein Description Required for anchoring dihydrolipoamide dehydrogenase (E3) to the dihydrolipoamide transacetylase (E2) core of the pyruvate dehydrogenase complexes of eukaryotes. This specific binding is essential for a functional PDH complex..
Protein Sequence MAASWRLGCDPRLLRYLVGFPGRRSVGLVKGALGWSVSRGANWRWFHSTQWLRGDPIKILMPSLSPTMEEGNIVKWLKKEGEAVSAGDALCEIETDKAVVTLDASDDGILAKIVVEEGSKNIRLGSLIGLIVEEGEDWKHVEIPKDVGPPPPVSKPSEPRPSPEPQISIPVKKEHIPGTLRFRLSPAARNILEKHSLDASQGTATGPRGIFTKEDALKLVQLKQTGKITESRPTPAPTATPTAPSPLQATAGPSYPRPVIPPVSTPGQPNAVGTFTEIPASNIRRVIAKRLTESKSTVPHAYATADCDLGAVLKVRQDLVKDDIKVSVNDFIIKAAAVTLKQMPDVNVSWDGEGPKQLPFIDISVAVATDKGLLTPIIKDAAAKGIQEIADSVKALSKKARDGKLLPEEYQGGSFSISNLGMFGIDEFTAVINPPQACILAVGRFRPVLKLTEDEEGNAKLQQRQLITVTMSSDSRVVDDELATRFLKSFKANLENPIRLA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Phosphorylation----MAASWRLGCDP
----CCCCCCCCCCH
11.8224043423
9 (in isoform 3)Phosphorylation-8.45-
15 (in isoform 3)Phosphorylation-27.60-
16PhosphorylationCDPRLLRYLVGFPGR
CCHHHHHHHHCCCCC
13.00-
25PhosphorylationVGFPGRRSVGLVKGA
HCCCCCCCHHCCCCC
21.12-
31 (in isoform 3)Phosphorylation-20.6822210691
50 (in isoform 3)Phosphorylation-39.9722210691
52 (in isoform 3)Phosphorylation-2.9322210691
58AcetylationWLRGDPIKILMPSLS
HHCCCCEEEEEECCC
34.8625038526
63PhosphorylationPIKILMPSLSPTMEE
CEEEEEECCCCCCCC
27.7530108239
64UbiquitinationIKILMPSLSPTMEEG
EEEEEECCCCCCCCC
6.1529967540
65PhosphorylationKILMPSLSPTMEEGN
EEEEECCCCCCCCCC
23.7430108239
67PhosphorylationLMPSLSPTMEEGNIV
EEECCCCCCCCCCCH
33.5630108239
75AcetylationMEEGNIVKWLKKEGE
CCCCCCHHHHHHCCC
42.9126051181
79UbiquitinationNIVKWLKKEGEAVSA
CCHHHHHHCCCCEEC
69.6429967540
95PhosphorylationDALCEIETDKAVVTL
CCEEEEECCCEEEEE
48.7627251275
97N6-lipoyllysineLCEIETDKAVVTLDA
EEEEECCCEEEEEEC
50.96-
97LipoylationLCEIETDKAVVTLDA
EEEEECCCEEEEEEC
50.96-
97LipoylationLCEIETDKAVVTLDA
EEEEECCCEEEEEEC
50.9625525879
101PhosphorylationETDKAVVTLDASDDG
ECCCEEEEEECCCCC
16.6027251275
105UbiquitinationAVVTLDASDDGILAK
EEEEEECCCCCEEEE
35.5829967540
105AcetylationAVVTLDASDDGILAK
EEEEEECCCCCEEEE
35.58-
120UbiquitinationIVVEEGSKNIRLGSL
EEEECCCCCEEECHH
68.2229967540
120AcetylationIVVEEGSKNIRLGSL
EEEECCCCCEEECHH
68.2225953088
139AcetylationVEEGEDWKHVEIPKD
EEECCCCCCEECCCC
50.5225038526
154PhosphorylationVGPPPPVSKPSEPRP
CCCCCCCCCCCCCCC
44.6227251275
157PhosphorylationPPPVSKPSEPRPSPE
CCCCCCCCCCCCCCC
65.0627251275
157UbiquitinationPPPVSKPSEPRPSPE
CCCCCCCCCCCCCCC
65.0629967540
158UbiquitinationPPVSKPSEPRPSPEP
CCCCCCCCCCCCCCC
54.5829967540
162PhosphorylationKPSEPRPSPEPQISI
CCCCCCCCCCCCEEC
43.0825159151
167UbiquitinationRPSPEPQISIPVKKE
CCCCCCCEECEEECC
6.2029967540
168PhosphorylationPSPEPQISIPVKKEH
CCCCCCEECEEECCC
18.6525159151
173UbiquitinationQISIPVKKEHIPGTL
CEECEEECCCCCCEE
55.5529967540
179AcetylationKKEHIPGTLRFRLSP
ECCCCCCEEEEEECH
14.9219608861
179AcetylationKKEHIPGTLRFRLSP
ECCCCCCEEEEEECH
14.92-
179PhosphorylationKKEHIPGTLRFRLSP
ECCCCCCEEEEEECH
14.9228857561
194AcetylationAARNILEKHSLDASQ
HHHHHHHHHCCCCCC
34.7419608861
196PhosphorylationRNILEKHSLDASQGT
HHHHHHHCCCCCCCC
38.7328857561
198UbiquitinationILEKHSLDASQGTAT
HHHHHCCCCCCCCCC
47.3829967540
200PhosphorylationEKHSLDASQGTATGP
HHHCCCCCCCCCCCC
28.8928857561
208UbiquitinationQGTATGPRGIFTKED
CCCCCCCCCEECHHH
52.7829967540
208MethylationQGTATGPRGIFTKED
CCCCCCCCCEECHHH
52.78115486811
213UbiquitinationGPRGIFTKEDALKLV
CCCCEECHHHHHHHH
42.7329967540
218AcetylationFTKEDALKLVQLKQT
ECHHHHHHHHHHHHH
48.6225953088
223UbiquitinationALKLVQLKQTGKITE
HHHHHHHHHHCCCCC
28.8229967540
223AcetylationALKLVQLKQTGKITE
HHHHHHHHHHCCCCC
28.8225953088
297PhosphorylationRLTESKSTVPHAYAT
HHCCCCCCCCCEEEC
41.6230576142
304PhosphorylationTVPHAYATADCDLGA
CCCCEEECCCCCHHH
15.4530576142
307GlutathionylationHAYATADCDLGAVLK
CEEECCCCCHHHEEH
4.2822555962
310AcetylationATADCDLGAVLKVRQ
ECCCCCHHHEEHHHH
10.61-
314UbiquitinationCDLGAVLKVRQDLVK
CCHHHEEHHHHHHHC
28.86-
321AcetylationKVRQDLVKDDIKVSV
HHHHHHHCCCCEEEH
57.9126210075
325AcetylationDLVKDDIKVSVNDFI
HHHCCCCEEEHHHHH
35.1423236377
364PhosphorylationQLPFIDISVAVATDK
CCCEEEEEEEEECCC
10.5625693802
369UbiquitinationDISVAVATDKGLLTP
EEEEEEECCCCCCHH
31.4829967540
369PhosphorylationDISVAVATDKGLLTP
EEEEEEECCCCCCHH
31.4825693802
375PhosphorylationATDKGLLTPIIKDAA
ECCCCCCHHHHHHHH
19.93-
379SuccinylationGLLTPIIKDAAAKGI
CCCHHHHHHHHHHCH
41.8723954790
3792-HydroxyisobutyrylationGLLTPIIKDAAAKGI
CCCHHHHHHHHHHCH
41.87-
379AcetylationGLLTPIIKDAAAKGI
CCCHHHHHHHHHHCH
41.87-
379UbiquitinationGLLTPIIKDAAAKGI
CCCHHHHHHHHHHCH
41.8729967540
384UbiquitinationIIKDAAAKGIQEIAD
HHHHHHHHCHHHHHH
52.3929967540
3842-HydroxyisobutyrylationIIKDAAAKGIQEIAD
HHHHHHHHCHHHHHH
52.39-
394SuccinylationQEIADSVKALSKKAR
HHHHHHHHHHHHHHC
47.78-
394AcetylationQEIADSVKALSKKAR
HHHHHHHHHHHHHHC
47.7823236377
394SuccinylationQEIADSVKALSKKAR
HHHHHHHHHHHHHHC
47.7827452117
394UbiquitinationQEIADSVKALSKKAR
HHHHHHHHHHHHHHC
47.7829967540
445UbiquitinationCILAVGRFRPVLKLT
EEEEEEECCEEECCC
9.47-
460UbiquitinationEDEEGNAKLQQRQLI
CCCCCCCEEEEEEEE
51.32-
468PhosphorylationLQQRQLITVTMSSDS
EEEEEEEEEEECCCC
20.6521406692
470PhosphorylationQRQLITVTMSSDSRV
EEEEEEEEECCCCCC
11.5921406692
472PhosphorylationQLITVTMSSDSRVVD
EEEEEEECCCCCCCC
22.9421406692
473PhosphorylationLITVTMSSDSRVVDD
EEEEEECCCCCCCCH
28.8721406692
475PhosphorylationTVTMSSDSRVVDDEL
EEEECCCCCCCCHHH
28.9921406692
476AcetylationVTMSSDSRVVDDELA
EEECCCCCCCCHHHH
37.15-
488AcetylationELATRFLKSFKANLE
HHHHHHHHHHHHHCC
51.6525825284
489PhosphorylationLATRFLKSFKANLEN
HHHHHHHHHHHHCCC
33.8424719451
491MalonylationTRFLKSFKANLENPI
HHHHHHHHHHCCCCC
43.3826320211
491MethylationTRFLKSFKANLENPI
HHHHHHHHHHCCCCC
43.387668025
491AcetylationTRFLKSFKANLENPI
HHHHHHHHHHCCCCC
43.3823749302

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseSPOPO43791
PMID:22199232

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
97KLipoylation

25525879

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ODPX_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ATRAP_HUMANAGTRAPphysical
25416956
EP300_HUMANEP300physical
11756538
NDF1_HUMANNEUROD1physical
11756538
IF2M_HUMANMTIF2physical
28514442
PPCEL_HUMANPREPLphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
245349Pyruvate dehydrogenase E3-binding protein deficiency (PDHXD)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ODPX_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-194, AND MASS SPECTROMETRY.

TOP